Conjunctival Melanoma in Youth: Case Report of an Asian Female

Main Article Content

Nur Athirah Binti Adnan
Nor Sharina Binti Yusof
Aniza Hassan
Jemaima Che Hamzah

Abstract

Background: Conjunctival melanoma (CM) is a rare ocular malignancy, typically affecting Caucasian males over 50. Its occurrence in young Asian females is extremely uncommon, posing diagnostic and therapeutic challenges.
Case Presentation: A 34-year-old Asian female with no comorbidities presented with a progressively enlarging medial right eye mass over 2-3 years. Examination revealed a hyperpigmented, papilliform conjunctival lesion with feeder vessels from 2 to 5 o’clock, encroaching the nasal cornea. She underwent wide excision biopsy, cryotherapy, and amniotic membrane grafting. Histopathology confirmed CM, positive for Melan-A. Tumor markers were negative. She received three cycles of topical mitomycin C (MMC) 0.02%. At latest follow-up, there was no recurrence.
Discussion: This case illustrates an unusual presentation of CM in a young Asian female. Early diagnosis and prompt surgical and adjuvant management are vital in preventing recurrence. Clinicians should maintain suspicion for CM even in low-risk demographics.
Key Messages: CM is rare in young Asian females, often leading to delayed diagnosis. This case highlights the importance of early clinical suspicion, prompt surgical management, and adjuvant therapy to prevent recurrence and improve outcomes in atypical presentations of this aggressive ocular malignancy.

Article Details

Section
Case Report

References

Kaštelan S, Gverović-Antunica A. Conjunctival melanoma - epidemiological trends and features. Pathol Oncol Res. 2018;24(4):787-96.

Gkiala A, Damato BE. Conjunctival melanoma: Update on genetics, epigenetics and targeted molecular and immune-based therapies. Clin Ophthalmol. 2020;14:3137-52.

Ditta LC, Shildkrot Y, Wilson MW. Outcomes in 15 patients with conjunctival melanoma treated with adjuvant topical mitomycin C: Complications and recurrences. Ophthalmol. 2011;118(9):1754-9.

Wong JR, Nanji AA, Galor A, Karp CL. Management of conjunctival malignant melanoma: A review and update. Expert Rev Ophthalmol. 2014;9(3):185-204.

Albreiki DH, Gilberg SM, Farmer JP. Conjunctival malignant melanoma: A rare variant and review of important diagnostic and therapeutic considerations. Saudi J Ophthalmol. 2012;26(2):151-6.

Dalvin LA, Ancona-Lezama D, Lucio-Alvarez JA, Mashayekhi A, Shields CL, Shields JA. Conjunctival melanoma: Outcomes based on age at presentation in 629 patients at a single ocular oncology center. Cornea. 2021;40(5):554-63.

Pe’er J, Finger PT. Conjunctival melanoma. In: Pe’er J, Damato BE, Singh AD, editors. Clinical Ophthalmic Oncology. Springer; 2024. 63–81 p.

Butt K, Hussain R, Coupland SE, Krishna Y. Conjunctival melanoma: A clinical review and update. Cancers (Basel). 2024;16(18):3121.

Cohen VML, O’Day R. Management issues in conjunctival tumours: Conjunctival melanoma and primary acquired melanosis. Ophthalmol Ther. 2019;8(4):521-34.

Saleem A, Narala S, Raghavan SS. Immunohistochemistry in melanocytic lesions: Updates with a practical review for pathologists. Pathol Res Pract. 2022;239(4):239-47.

Nahon-Estève S, Basli E, Gastaud P, Gastaud L. Small but challenging conjunctival melanoma: New insights, paradigms and future perspectives. Cancers (Basel). 2021;13(22):5691.

Souza LCA, Mendes SLB. Conjunctival melanoma and role of immunohistochemical markers protein S100, HMB-45 and Melan A in tumor staging: Case report and literature review. J Surg Curr Trends Innov. 2019;3(1):1-6.